Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Assets (2016 - 2025)

Historic Return on Assets for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to 0.15%.

  • Abeona Therapeutics' Return on Assets rose 5500.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 5500.0%. This contributed to the annual value of 0.79% for FY2024, which is 500.0% down from last year.
  • As of Q3 2025, Abeona Therapeutics' Return on Assets stood at 0.15%, which was up 5500.0% from 0.23% recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Return on Assets registered a high of 0.23% during Q2 2025, and its lowest value of 2.04% during Q3 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.73% (2024), whereas its average is 0.72%.
  • Per our database at Business Quant, Abeona Therapeutics' Return on Assets tumbled by -15400bps in 2022 and then soared by 12500bps in 2023.
  • Over the past 5 years, Abeona Therapeutics' Return on Assets (Quarter) stood at 0.94% in 2021, then decreased by -7bps to 1.0% in 2022, then increased by 27bps to 0.73% in 2023, then skyrocketed by 33bps to 0.49% in 2024, then surged by 130bps to 0.15% in 2025.
  • Its Return on Assets stands at 0.15% for Q3 2025, versus 0.23% for Q2 2025 and 0.59% for Q1 2025.